ONON reported an impressive Q1 performance with 40% sales growth and upgraded 2025 guidance. Click to know why ONON stocks ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 7 undervalued ...

Foreign industry is expected to remain resilient on the solid growth momentum of Chinese auto players. Japan’s growing ...

The Bottom line,” said Loe, is that there is “no denying that FQ225 financial data were soft by Quipt’s own standards, and we ...

Enterprise Products Partners LP EPD appears undervalued, currently trading at a trailing 12-month enterprise value to EBITDA ...

TopBuild excels in construction with strong Q1'25 results, disciplined management, and growth initiatives. Click to know if ...

T1 has signed 253 MW 2025 sales agreement with U.S. utility-scale developer. This sales agreement, which is the first new ...

CNW/ - Keyera Corp. (TSX: KEY) ("Keyera") announced its first quarter financial results today, the highlights of which are ...

The Oncology Institute, Inc. (NASDAQ: TOI) ("TOI" or the "Company"), one of the largest value-based community oncology groups in the United States, ...

Inpex reported a 4% increase in underlying first-quarter 2025 net profit after tax to JPY 126 billion against the previous corresponding period, or pcp. Lower depreciation and tax underpinned the ...

Spirax has a sound balance sheet and financial health. Its net debt to EBITDA ratio sits at 1.5 times on depressed earnings due to customer destocking at Watson-Marlow. Spirax remains comfortably ...